loader from loading.io

#582: GLP-1 Agonists: Side Effects, Management and Diet – Dr. Spencer Nadolsky

Sigma Nutrition Radio

Release Date: 10/28/2025

#606: Practical Nutrition Strategies for Fat Loss – Luke Hanna show art #606: Practical Nutrition Strategies for Fat Loss – Luke Hanna

Sigma Nutrition Radio

Body composition goals, particularly bodyfat loss, are among the most common reasons people seek support from a nutritionist or health and fitness professional. While the principles are well established, the challenge is helping individuals apply them consistently in real-world conditions. Many people struggle due to hunger, unrealistic expectations, emotional eating, inconsistent routines, or overly restrictive dieting approaches. These challenges can make fat loss difficult to sustain, even when someone understands what they “should” be doing. In this episode,  Luke Hanna discusses...

info_outline #605: Fasting, Nutrient Timing & CGMs: Interpreting the Evidence – Prof. James Betts show art #605: Fasting, Nutrient Timing & CGMs: Interpreting the Evidence – Prof. James Betts

Sigma Nutrition Radio

Fasting, nutrient timing, chrono-nutrition, and continuous glucose monitoring are all topics that have generated substantial interest, but they are also areas where exaggerated claims can easily outpace the underlying evidence. In many cases, tentative hypotheses are presented as if they were already well-established conclusions, despite the fact that the research base is often more mixed and context-dependent than popular narratives imply. It is one thing for an idea to appear biologically coherent. It is another for that idea to translate into meaningful, reliable effects in real-world...

info_outline #604: How To Interpret Nutrition Research – David Allison, PhD show art #604: How To Interpret Nutrition Research – David Allison, PhD

Sigma Nutrition Radio

How should we decide what counts as trustworthy evidence? Scientific rigor is not a single characteristic of a study, but a chain of decisions made from the moment a question is conceived to the point at which findings are communicated to the public. Errors can occur at every stage: the question may be ill-posed, the design may be incapable of answering it, the measurements may be weak, the analysis may be inappropriate, the interpretation may overreach, and the public-facing communication may become distorted. In this episode, Dr. David Allison, PhD discusses the deeper methodological issues...

info_outline #603: Should Dietary Fiber Be Considered Essential? – Andrew Reynolds, PhD show art #603: Should Dietary Fiber Be Considered Essential? – Andrew Reynolds, PhD

Sigma Nutrition Radio

Dietary fiber is widely recognized as an important component of a healthy diet, yet it is not typically classified as an essential nutrient. In this episode, Dr. Andrew Reynolds explores whether that distinction still holds, arguing that the traditional criteria used to define essentiality may be outdated when applied to modern nutrition science. The discussion moves beyond simply acknowledging the benefits of fiber and instead examines whether it meets the foundational requirements of an essential nutrient. This includes considering its physiological roles, the body’s inability to...

info_outline #602: Avoidant/Restrictive Food Intake Disorder (ARFID) – Megan Hellner, DrPH, RD & Katherine Hill, MD show art #602: Avoidant/Restrictive Food Intake Disorder (ARFID) – Megan Hellner, DrPH, RD & Katherine Hill, MD

Sigma Nutrition Radio

Avoidant/Restrictive Food Intake Disorder (ARFID) is an eating disorder diagnosis characterized by a persistent restriction or avoidance of food intake that results in clinically significant consequences (medical, nutritional, and/or psychosocial), but without the weight- and shape-driven psychopathology typical of anorexia nervosa and bulimia nervosa. In this episode, Megan Hellner and Katherine Hill outline how ARFID presents across the lifespan, why it is frequently missed in routine healthcare, and what an evidence-informed assessment and treatment pathway can look like in practice. A...

info_outline #601: Gallstones & Gallbladder Conditions: Impact of Diet – Angela Madden, PhD RD show art #601: Gallstones & Gallbladder Conditions: Impact of Diet – Angela Madden, PhD RD

Sigma Nutrition Radio

This episode examines what we actually know (and importantly, what we do not know) about diet in relation to gallstones and gallbladder conditions. Much of the public-facing guidance around gallstones focuses on “avoiding fatty foods”, yet Dr. Angela Madden explains that this long-standing practice sits on surprisingly weak direct evidence, particularly when judged against the standards typically expected for clinical dietary recommendations. A central theme is the need to separate two distinct questions: dietary factors that influence the risk of developing gallstones (prevention), versus...

info_outline Coevolution With Foods? Multivitamins? Eating Too Early? – Ask Me Anything (SNP49) show art Coevolution With Foods? Multivitamins? Eating Too Early? – Ask Me Anything (SNP49)

Sigma Nutrition Radio

In this episode, Danny answers questions submitted by Premium subscribers. Questions Answered in This Episode: [00:05:13] Is eating too early (relative to chronotype) metabolically problematic? [00:16:55] Can plant-based diets reverse cardiovascular disease? [00:32:54] Are multivitamins useful insurance, or a waste with a good diet? [00:44:56] Does coevolution with foods determine human compatibility and benefit? [00:56:25] How should consumers choose supplement formulations and brands? [01:04:46] Folate vs folic acid: differences and best choice for women of...

info_outline #600: Finite Knowledge, Infinite Ignorance show art #600: Finite Knowledge, Infinite Ignorance

Sigma Nutrition Radio

“The more we learn about the world, and the deeper our learning, the more conscious, specific, and articulate will be our knowledge of what we do not know, our knowledge of our ignorance. For this, indeed, is the main source of our ignorance — the fact that our knowledge can be only finite, while our ignorance must necessarily be infinite.” – Karl Popper To mark Sigma Nutrition’s milestone 600th episode (and 12-year anniversary), Danny and Alan examine several areas in which their views have changed, softened, strengthened, or remained stable over the lifespan of the podcast....

info_outline #599: Does Unprocessed Red Meat Increase Diabetes Risk? – Gil Carvalho, PhD MD & Mario Kratz, PhD show art #599: Does Unprocessed Red Meat Increase Diabetes Risk? – Gil Carvalho, PhD MD & Mario Kratz, PhD

Sigma Nutrition Radio

This episode examines whether unprocessed red meat has a causal role in (1) type 2 diabetes risk and intermediate measures of glucose intolerance (insulin resistance, beta cell dysfunction, glycemic markers) and (2) cardiovascular disease (CVD) risk. While there is commonly observed risk signal from observational cohorts, there exist short-term randomized controlled trials (RCTs) that show largely null effects on glucose homeostasis. This had led to differing opinions and interpretations of the evidence base. Some feel that in the context of an otherwise healthy diet, there isn’t much to...

info_outline #598: How Do Exercise & Diet Interact to Improve Glycaemic Control? – Jenna Gillen, PhD show art #598: How Do Exercise & Diet Interact to Improve Glycaemic Control? – Jenna Gillen, PhD

Sigma Nutrition Radio

This episode examines how exercise and nutrition interact to influence glycaemic control, with particular focus on the postprandial period (i.e., the hours after eating) and on “time-efficient” exercise strategies such as low-volume interval training. Dr. Jenna Gillen outlines the physiological basis for why muscle contraction can acutely reduce post-meal glucose excursions, why repeated sessions can accumulate into longer-term improvements in insulin sensitivity, and why the nutrition context (pre- and post-exercise feeding, carbohydrate availability, and energy balance) can meaningfully...

info_outline
 
More Episodes

GLP-1 receptor agonists have emerged as a groundbreaking tool in obesity treatment. In this episode, Dr. Spencer Nadolsky (an obesity specialist) explains how these medications are now yielding unprecedented weight loss outcomes in people with obesity. 

The discussion centers on GLP-1 agonist drugs like semaglutide and tirzepatide: how they work, how much weight loss they can produce, and why they represent a paradigm shift in obesity management. 

Importantly, the conversation addresses practical aspects of using these drugs, including managing their side effects and optimizing patients’ diet and lifestyle while on therapy.

This topic is of great significance to nutrition science, clinical practice, and public health. Obesity is a chronic, relapsing condition that has proven difficult to treat with lifestyle changes alone. The advent of GLP-1 agonists offers new hope by inducing weight loss levels previously seen only with surgical interventions. 

Understanding these medications is crucial for healthcare professionals: it enables evidence-based prescribing, proper patient counseling on diet and side effects, and integration of medication with lifestyle interventions. 

Discussing safety and long-term use is vital, as millions more patients might use these drugs in coming years. From a public health perspective, GLP-1 agonists prompt debates about access and cost, given their high price and life-changing potential.

Timestamps

  • [03:25] Conversation with Dr. Spencer Nadolsky begins
  • [05:24] Mechanism and types of GLP-1 medications
  • [07:55] Efficacy and weight loss results
  • [16:53] Common side effects and management
  • [22:57] Muscle loss concerns and clinical insights
  • [28:09] Addressing nutritional concerns with GLP-1 medications
  • [29:38] Exploring potential benefits beyond weight loss
  • [33:48] Marketing and misconceptions around GLP-1
  • [36:59] Public health and accessibility issues
  • [43:25] Future research
  • [46:16] Key ideas segment (Premium-only)

Related Resources